Schwab Andrew J. insider trades

Schwab Andrew J. has filed 34 Form 4s with the SEC that we hold, for Skye Bioscience, Inc. (SKYE) (Director, 10% owner), Camp4 Therapeutics Corp (CAMP) (Director), Enliven Therapeutics, Inc. (ELVN) (10% owner) and Entrada Therapeutics, Inc. (TRDA) (10% owner), among 9 companies in all. Across all of them we count 2 purchases worth $15.0M and 47 sales worth $19.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 20 sales ($2.9M). The largest single trade was a purchase of 909,090 shares of Camp4 Therapeutics Corp worth $10.0M, dated 2024-10-15. Of 20 sales filed since we began reading the 10b5-1 checkbox, 0 (0%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-11-04 and the latest 2026-09-24.